Date07/03/2012AuthorНаталья РайбманSourceVedomostiPreserved copyInternet ArchiveOriginal MaterialShow translationGlaxoSmithKline заплатит $3 млрд за нарушения в продвижении лекарств в СШАOur archive does not currently contain the full version of this documentWhere to read:Preserved copyLink to original version